Distinct RBC metabolic signatures correlate with elevated HbA1c in beta-thalassemia heterozygotes, suggesting new biomarkers for personalized medicine.
Distinct RBC metabolic signatures were observed in BTHs with elevated HbA1c, highlighting alterations in redox and heme metabolism. These findings provide a basis for future investigations into RBC-derived metabolites as complementary tools for glycemic assessment in individuals with thalassemia and hemoglobinopathies.
No takes yet. Share an insight, caveat, or question.
Nuinoon et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: